Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Cdninvstron Feb 08, 2010 7:25pm
335 Views
Post# 16764499

RE: RE: RE: convertibles

RE: RE: RE: convertiblesC'mon Consultant. Risk adverse lenders don't buy the debt of unprofitable companies. Lets look at this from the bondholder's perspective. They bought their bonds back when the share price was something like 15 cents. At that share price the deal was that they could convert at the 13 cent price. A few cents per share cheaper than the going rate to take on the added risk of owning shares rather than bonds. These bondholders bought the debt of this company when its back was against the wall...no profit...no pennsaid FDA approval...WF-10 failures. These people deserve the 13 cent price if they so choose to convert. I'm wondering about the timing of this buyback, given the lacklustre share performance of late, but if you believe like I believe...like the bondholders believed way back when the share price was 15 cents....in the long run Nuvo will be a winner and we'll all make money. That being said, I'd be happy to see Covidien take us out for as little as 75 cents per share.
Bullboard Posts